BIOGEN revenue for the last year amounted to 9.35 B EUR, the most of which — 9.29 B EUR — came from its highest performing source at the moment, Innovative Therapies, the year earlier bringing 8.91 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought BIOGEN 5.13 B EUR, and the year before that — 4.92 B EUR.